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Amyloid A  fibrils  accumulate in  human tissues  during amyloidosis secondary to 
diseases  characterized  by  recurrent  inflammation,  and  in  tissues  of experimental 
animals  that  have been  subjected  to repeated  or chronic inflammatory stimulation 
(1-3). Antibodies to the amyloid A  fibril protein  (AA)  1 cross-react with a  protein in 
serum which is called serum amyloid A (SAA) (4, 5). SAA has an apparent mol wt of 
160,000-180,000 (6, 7) and has the same density as high density lipoproteins,  1.15 g/ 
cc in  man  (8)  and  1.13  g/cc in  mouse  (J.  Sipe,  unpublished  observations).  SAA is 
converted  to  a  species  of  12,000-13,000  mol  wt  upon  gel  filtration  in  dissociating 
agents (6-8), and there is considerable homology between the amino acid sequences 
of this denatured SAA and that of the 8,000- to 10,000-mol wt AA polypeptide which 
is solubilized from amyloid A fibrils (2, 9). SAA concentrations are elevated in chronic 
inflammatory and neoplastic diseases  (10,  11), and it  has been documented in man 
(12) and mouse (13) that SAA is an acute phase protein whose concentration in serum 
is highly increased after an inflammatory stimulus. 
Despite study, the mechanism by which SAA is produced remains unknown. SAA 
has been found in fibroblasts and connective tissues  (14),  and in vitro SAA synthesis 
by cultured polymorphonuclear leucocytes has been observed (15).  During an acute 
phase  response  to  inflammation,  SAA synthesis  (16)  occurs in  hepatocytes  (17),  as 
does synthesis of the  quintessential  acute phase  reactant, C-reactive protein  (CRP) 
(18).  In  a  previous  study  (19),  we  demonstrated  that  lipopolysaccharide  (LPS)- 
sensitive  lymphocytes and  macrophages were  necessary  for LPS-induced SAA pro- 
duction, indicating a  primary role for these cells  in  the acute phase  SAA response. 
LPS has been shown to induce production of a mediator, glucocorticoid antagonizing 
factor (GAF), that acts on hepatocytes (20).  We have therefore investigated whether 
a similar type of mediator might be involved in SAA production. 
C3H/HeJ  mice  do  not  produce a  significant  SAA response to  phenol  extracted 
Escherichia  coli  K235  LPS,  in  contrast  to  C3H/HeN  mice  which  exhibit  a  several 
hundred-fold increase in SAA-concentration at the peak of the acute phase response 
to  endotoxin  (13).  We  have  therefore  utilized  this  strain  pair  to  investigate  the 
i Abbreviations used in this paper: AA, antibodies to the amyloid A fibril protein; CRP, C-reactive protein; 
GAF, glucocorticoid  antagonizing factor; LPS, lipopolysaccharide; SAA,  serum amyloid A. 
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possibility of an  SAA  inducer and  have  found  that  macrophages  make  an  SAA 
inducer in response to  LPS.  These  findings demonstrate the  mechanism by which 
LPS produces increased SAA concentrations and lay a logical framework for explain- 
ing how chronic inflammation may result in amyloidosis. 
Materials and Methods 
Mice.  Female C3H/HeN mice, aged 6-10 wk, were obtained from the Division of Research 
Resources,  National Institutes of Health, Bethesda,  Md.  Female and male C3H/HeJ  mice, 
aged 4-8 wk, were obtained from The Jackson Laboratory, Bar Harbor, Maine. No significant 
sex  differences  have been observed  in the  acute  phase  response of C3H  or  other  mice to 
endotoxin although males tend to fight and elevated SAA concentrations have been observed 
in these injured mice (K. McAdam and J. Sipe, unpublished results).  Serum containing SAA 
inducer was obtained by bleeding C3H/HeN mice from the orbital plexus between 2 and 2.5 
h  after the i.p.  administration of K235 LPS (1  /ag in 0.2  ml of pyrogen-free saline). Control 
serum was obtained from untreated or saline-injected  animals as specified. 
Adoptive transfer of bone marrow cells was carried out with C3H/HeJ or C3H/HeN bone 
marrow  cells  prepared  from  12-wk-old  mice  by  the  method  of  Michalek  and  co-workers 
(Suzanne Michalek, personal communication). The method consists of grinding femurs and 
tibias in RPMI-1640 medium, filtering the suspended cells  through gauze to remove small 
pieces of bone, and suspending the cells at a concentration of 10S/ml for injection. Chimeric 
mice were tested 5 wk after adoptive transfer for their ability to produce SAA inducer. 
Reagents.  Endotoxin  was  prepared  from  E.  coli K235  by  the  phenol-water  extraction 
procedure of Mclntire et al. (21). The dose response curve for SAA induction in C3H/HeN and 
C3H/HeJ mice was similar to that reported earlier (13). With the present preparation of LPS, 
<5/tg/ml SAA was induced by 5 #g LPS after 18 h in C3H/HeJ mice, whereas ~ 1,000/Lg/ml 
SAA  was  induced in C3H/HeN  mice.  Sterile  thioglycollate broth  was  obtained from  the 
National Institutes of Health  Media  Unit.  RPMI-1640  medium  (Grand Island Biological 
Company, Grand Island, N. Y.) was supplemented with penicillin (100 U/ml), streptomycin 
(100/Lg/ml), glutamine (2 mM), and 15 mM Hepes buffer. 
Production of SAA Inducer by LPS-Treated Cell Cultures.  Mice were injected with 3 ml of sterile 
thioglycollate i.p. and 6 d later the induced peritoneal exudate cells were collected by peritoneal 
lavage with pyrogen free saline (Abbott Diagnostics, Diagnostic Products, Chicago, Ilk). These 
cells  were  routinely found  to  be  >90%  macrophages  by  differential  staining of cytospin 
preparations (Shandown Southern Products Limited, Runcorn, Cheshire, England). Adherent 
cells were obtained by incubation of 2  X  106 peritoneal exudate cells in serum-free RPMI in 
TC-24 culture dishes  (Costar, Data Packaging, Cambridge, Mass.) at 37°C for 3 h after which 
the nonadherent cells were removed by washing. Adherent cell monolayers contained >98% 
macrophages.  In  some  experiments,  the  nonadherent cells  were  not  removed.  Spleen  cell 
preparations were  prepared by teasing the spleens and resuspending the washed cells to 2  X 
106 spleen cells/ml in serum-free RPMI. Cells were incubated with or without 10/.tg/ml LPS. 
SAA Measurements.  SAA concentration was estimated in serum obtained by bleeding animals 
from the orbital plexus at various times after injection of serum from LPS-treated C3H/HeN 
or C3H/HeJ mice, or medium from LPS-treated cell cultures. A  10-/LI aliquot of serum to be 
tested for SAA was added to 500/A of 10% formic acid and incubated for 24 h at 56°C. Either 
the entire dilution, or aliquots of it, was lyophilized and resuspended in casein barbital buffer, 
and the SAA concentration was estimated according to the capacity of the sample to compete 
with  I2SI-AA binding by immobilized anti-AA antibodies (22). Each dilution of sample was 
assayed  in duplicate on at least  two separate occasions.  At least  10 samples were employed to 
normalize the data for immunoassays  carried out on separate occasions. The SAA concentration 
for individual animals was averaged for the multiple determinations, and the arithmetic mean 
and SEM determined. The SEM is indicated after each mean concentration of SAA. Occasion- 
ally, as is indicated in the legends, a single value was discarded if its value was greater than the 
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FIc.  1.  Appearance of SAA in C31|/tteJ mice.  (a)  0.2  ml of serum from  C3tt/HeN mice 2.5  h 
after i.p. injection of 1 /~g of LPS was administered i.p. to C3H/HeJ mice. The SAA concentration 
of the injected serum was 10/~g/ml. (b) LPS,  I/~g in 0.2 ml pyrogen free saline was administered to 
C3H/HeJ mice. (c) 0.2 ml of serum from untreated C3H/HeN mice was administered to C31t/HeJ 
mice. The SAA concentration of the administered serum was <1/Lg/ml. Male C3t t/tleJ mice, 6 wk 
old, were employed. Each point represents the arithmetic mean of the SAA determination for serum 
of three individual animals. The  horizontal bars  represent  the mean  +  SEM.  Two  values were 
discarded:  1-LPS 2.5 h and  I-LPS  1.5 h. 
Results 
Detection of SAA Inducer in Serum of LPS-Treated Mice. The process of SAA induction 
in C3H/HeN mice by LPS has been characterized previously (13,  16). Initially there 
is a  2-3 h  latent  period before the SAA concentration  begins to rise; then there is a 
period  of synthesis during which  the  SAA concentration  increases exponentially  to 
almost  1,000/~g/mi  by  16-24  h- after treatment  with  5 #g or more LPS;  and  lastly 
there is a  deinduction  period during which  the SAA concentration  returns to prein- 
duction levels by 48 h  after LPS treatment. C3H/HeJ mice show a  diminished SAA 
response to all forms of endotoxin and in particular to K235 phenol-extracted  LPS. 
At the peak of the acute phase response, 5/lg of K235  LPS elicits <5/.tg/ml SAA in 
C3H/HeJ mice as compared with  1,000/~g/ml in C3H/HeN mice (13). 
In the present study it was found that serum from C3H/HeN mice obtained 2.5 h 
after  administration  of LPS,  which  is  at  the  end  of the  latent  period  before  the 
normally observed exponential rise in SAA concentration, was capable of stimulating 
SAA synthesis by C3H/HeJ mice. This data is shown in Fig.  1. The SAA concentration 
in C3H/HeJ sera was observed to increase between  1.5 and 2.5 h  after i.p.  injection 
of 0.2 ml of serum from C3H/HeN mice treated with  1 /~g of LPS, and rose to ~100 
/lg/ml  by 5.5  h  (Fig.  la).  The same quantity  of LPS  did  not  stimulate significant 
quantities  of  SAA  in  C3H/HeJ  mice  (Fig.  lb)  although  it  did  elicit  an  SAA 
concentration of 185 #g/ml  in C3H/HeN mice 5.5  h  after administration  (data not 
shown). Serum from untreated C3H/HeN mice did not stimulate SAA in C3H/HeJ 
mice  (Fig.  lc),  nor  did  serum  from  C3H/HeJ  mice  obtained  2.5  h  after  the  i.p. 
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FIo. 2.  Time course of appearance of SAA mediator in serum of C3H/HeN mice after either i.p. 
or i.v. injection of 1 /~g of LPS. The mediator was induced in seven groups of eight C3H/HeN 
female mice, 6 wk old. Each of the mice was injected with 1 /.tg of LPS in 0.5 ml of pyrogen free 
saline and bled 0,  15, 30, 60, 90, or  180 rain later. The seventh group was used as a control. To 
determine the presence of SAA inducer, 0.2  ml of pooled serum from each of the groups was 
administered i.p. to each of eight female C3H/HeJ  mice, 6 wk old. Each point represents the 
arithmetic mean of the eight individual sera +  SEM, except for the 0-min i.p. group for which one 
high value was discarded. 
SAA inducer is present in serum of C3H/HeN  mice at maximal concentrations by 
~90 min after administration of 1/tg LPS, and has begun to diminish by the end of 
the latent period of SAA induction, at the beginning of the exponential rise in SAA 
concentration  (Fig.  2).  The  time  course  is  similar  for  induction of  SAA  inducer 
whether the i.v. or i.p. route of administration of LPS is employed. Injection of LPS 
intravenously leads to the appearance of higher concentrations of both SAA inducer 
and SAA (Fig 2) as compared with the i.p. route. This may be due to a  dose response 
effect resulting from effectively higher concentrations of LPS and LPS-derived SAA 
inducer in the blood stream when the i.v. route is employed. However, it has been 
experimentally convenient to  employ  the  i.p.  route  for  the  preparation  of  large 
quantities of SAA inducer. 
The time course  for  induction of SAA by serum  SAA inducer is much different 
than the profile typically obtained for the acute phase SAA response to LPS (Fig. 3). 
When SAA is induced in C3H/HeJ  mice with 0.2  ml of latent period serum  (SAA 
<  10 ~g/ml) from C3H/HeN  mice treated with  1 ~g of LPS, the SAA concentration 
is 30-90/~g/ml (Figs.  1 and 3)  by 4  h  after administration, and this is ~50% of the 
maximum concentration observed (Fig. 3). In contrast, the acute phase SAA response 
of C3H/HeN  mice to LPS itself is marked by a  1,000-fold increase in SAA concentra- 
tion which has reached only 5-10% of its maximum value at 4 h  (16). This is consistent 
with the premise that SAA is not induced in C3H/HeJ  mice by passively transferred 
LPS. Furthermore, the data shown in Figs. 3 and 4 indicate that 0.2 ml of serum from 
C3H/HeN  mice given 1 #g of LPS stimulated up to  100-fold greater SAA concentra- 
tions in C3H/HeJ  mice than did  1 btg of LPS itself. 
The dose dependence of SAA induction by serum SAA inducer is shown in Fig. 4. 
The minimum vol of serum that can be feasibly employed appears to be 0.2 ml. Note SIPE,  VOGEL,  RYAN,  McADAM, AND  ROSENSTREICH 
./~Serum  from LPS-Treated 
4O 
20 
~  "12  ~ 
0  5  10  15  20  25 
HOURS AFTER  INJECTION 
Fro.  3.  Time course of induction of SAA in C3H/HeJ mice by latent period serum from C3H/ 
HeN mice and by LPS.  Female C3H/HeJ mice 6 wk old were employed. 0.2 ml of either serum 
from C3H/HeN mice treated with I #g of LPS or I #g of LPS in pyrogen-free saline were injected 
into each C3H/HeJ  mouse i.p.  Six  mice were bled for each time point  indicated.  Each  point 
represents the mean +  SE, for all six mice except for the 4- and the l~i-h LPS points for which one 
high value each was discarded. 
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FIG. 4.  Dose dependence of SAA induction by serum inducer. 25 C3H/HeN mice were given  1 
btg of K235  LPS i.p.  and bled 2.5  h  later.  The serum was collected from the pooled blood and 
immediately administered i.p.  to six C3H/HeJ  mice (12 wk old)  for each specified  volume.  The 
SAA concentration for the pool was subsequently determined to be 10 #g/ml. 
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that  0.5  ml  of serum  was  >100-fold  more  effective than  LPS  in  stimulating  SAA, 
when volume factors are taken into account. 
Evidence for the Production of SAA Inducer by Macrophages. The  resistance of C3H/HeJ 
mice  to  mount  an  acute  phase  SAA  response  to  LPS  appears  to  be  caused  by  a 
lymphoid  cell  defect  in  the  ability  to  respond  to  LPS  by  formation  of the  SAA 
inducer.  Evidence for  this  was  obtained  using chimeric animals  (Table  I).  Pooled 
serum from 10 C3H/HeJ  mice to which had been adoptively transferred bone marrow 
cells from C3H/HeN  mice, induced a  mean SAA concentration of 11  #g/ml, whereas 602  DETECTION  OF  A  MEDIATOR  THAT  INDUCES  MOUSE  SAA  RESPONSE 
TABLE  I 
Production of SAA Inducer by LPS-treated Chimeric Mice 
Mice  LPS  SAA inducer 
#g/ml SAA 
C3H/HeN BM ~  C3H/HeJx  +  11  ±  2 
C3H/HeJ BM ~  C3H/HeJx  +  3 _  1 
C3H/HeN  +  30 ±  6 
C3H/HeN  -  < l 
0.2  ml  pooled serum  from  10  mice  in each  of the  four groups above was 
administered i.p.  to C3H/HeJ  female mice (5 wk old). The arithmetic mean 
and its SE was obtained from all 7 animals in group  1, for 7 of 9 animals for 
group 2, for 9 of 10 animals in group 3, and for all 9 animals in group 4. The 
SAA concentration of the administered serum was <2 #g/ml in all cases. 
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FIG.  5.  Induction of SAA in C3H/HeJ mice by LPS-treated peritoneal exudate cells from C3H/ 
HeN mice. 1 ml of SAA-free culture medium was injected i.p. to each of six 6-wk-old  females which 
were bled 18 h later. Each value shown is the arithmetic mean with its SE in brackets. The amount 
of SAA induced by 0.2 ml serum from C3H/HeN mice 2.5 h after LPS and by 0.2 ml serum from 
untreated mice is indicated to the right of the graph. 
pooled  serum  from  10  C3H/HeJ  mice  reconstituted  with  C3H/HeJ  bone  marrow 
cells  induced  a  mean  SAA  concentration  of 3  #g/ml.  These  values  are  statistically 
significant  with  P  <  0.01.  In  the  same  experiment,  latent  period  serum  from  LPS- 
injected  normal  nonreconstituted  C3H/HeN  mice  induced  30 #g/ml  SAA  in  C3H/ 
HeJ  mice. 
Further  evidence for the derivation of SAA inducer from bone marrow-derived  cells 
comes from the data  shown in Fig. 5. Thioglycollate-induced  peritoneal macrophages 
were  incubated  for  varying  lengths  of  time  with  10  #g/ml  LPS,  and  the  culture 
medium  was harvested,  filter sterilized, and  injected i.p.  into C3H/HeJ  mice.  About 
30% of the maximal  amount  of SAA inducer was detected  in the culture  medium  by 
6  h,  indicating  that  the  in  vitro  SAA  inducer  is  potentially  the  same  one  which  is 
acting  in  vivo.  Furthermore,  it  can be seen that  1  ml of the culture  medium  from  2 
X  106 peritoneal cells is as effective as 0.2 ml of serum  from C3H/HeN  mice given  1 
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TABLE II 
Effect of Extensive Washing on Ability of Peritoneal Exudate Cells to Produce SAA Inducer In  Vitro in 
Response to Endotoxin 
Cell population 
SAA induce-r* 
Control  n  LPS (10 gg/ml)  n 
C3H/HeN PEC (nonadherent cells pres- 
ent) 
C3H/HeN ADH (extensively washed to 
remove nonadherent cells) 
ILg/rnl SAA  p.g/ml SAA 
8.2  ±  1.8  (7/8)  79.2 +  14:8  (8/8) 
10.5 :t: 3.4  (6/8)  84.1  +_  14.8  (7/7) 
* Culture  medium was obtained  as described in Materials and Methods.  1 ml was injected into seven or 
eight  animals. The  mean  and  its  SE  were computed  from the  number  of animals  indicated  in  the 
numerator. 
TABLE III 
Comparison of Ability of Endotoxin  to Stimulate SAA Inducer in  Various Cell 
Populations 
Cell population 
SAA 
Control  LPS (10 ~g/ml) 
#g/ml 
C3H/HeN PEC  0.9 zt: 0.2  44.3 +  1.7 
C3H/HeN spleen cells  5.6  +  1.6  5.0 +  2.1 
C3H/HeJ PEC  2.8  -  0.7  6.7  +  1.8 
Culture  medium was obtained  as described in Materials and Methods.  1 ml 
was injected into six animals, and the mean and its SE were computed for all 
six animals in each case. 
The macrophage origin of LPS-derived SAA inducer is further supported  by  the 
data shown in Table II. Washed, adherent  peritoneal exudate cells were as effective 
in  producing SAA inducer in  response  to  LPS  as  was  the entire cell population.  In 
contrast,  LPS-stimulated  spleen  cells  from  C3H/HeN  mice  did  not  make  SAA 
inducer, nor did LPS-stimulated macrophages from C3H/HeJ  mice (Table III). 
Discussion 
We have shown that the endotoxin-induced acute phase SAA response involves two 
distinct populations of cells. We have detected a  factor that appears in serum during 
the initial or "latent" part  of the acute phase SAA response to endotoxin which can 
stimulate SAA synthesis  in mice that  are resistant  to the acute phase stimulus itself. 
The idea, put forth by Rosenstreich and McAdam (19), that a  lymphoid cell may be 
responsible for initiating the SAA response to endotoxin is supported by the evidence 
presented  herein  that  chimeric C3H/HeJ  mice reconstituted  with  C3H/HeN  bone 
marrow cells are capable of producing the SAA inducing factor in response to LPS. 
It  appears  likely  that  the  SAA  inducer  arises  from  the  interaction  of  LPS  with 
macrophages,  in  view of the observation that  SAA inducer can be obtained in vitro 
by endotoxin stimulation of thioglycollate-induced C3H/HeN  macrophages but  not 
from a  population  of LPS-treated  C3H/HeN  spleen cells that  contains <10%  mac- 604  DETECTION OF A MEDIATOR THAT INDUCES MOUSE SAA RESPONSE 
rophages.  SAA inducer begins to appear in  culture  medium within  the  first 6  h  of 
LPS treatment; thus, it is possible that the in vitro and in vivo inducers are the same. 
Preliminary results (J. Sipe, unpublished observations) indicate that the serum SAA 
inducer is a trypsin-sensitive macromolecule, the activity of which is markedly reduced 
by incubation of latent period serum at 37°C. 
The possibility that the SAA inducing  factors observed both in vivo and in vitro 
might arise artifactually by transfer of a precursor of SAA would seem to be ruled out 
by the  fact  that  the  SAA  concentrations  of both  latent  period  serum  and  culture 
medium  were  minimal.  As  formic  acid  denaturation  is  always  employed  for  the 
antigenic assay of SAA, it seems unlikely that nonimmunoreactive AA determinants 
are being transferred. 
At  present,  little  can  be  said  about  the  chemical  nature  of SAA  inducer.  Our 
present understanding of the origin of acute phase reactants (23)  would suggest that 
SAA  inducer  arises  from  macrophage injury  by endotoxin  and  that  SAA  inducer 
subsequently stimulates the SAA synthesizing cell. It is tacitly assumed in this concept 
that the inducer is a cell product rather than a product of the inflammatory stimulus 
itself. This seems reasonable, in view of the wide range of agents which can induce 
acute phase reactants such as SAA and CRP and in  view of the fact that  localized 
inflammation can bring about a strong SAA response (12;  A. Weinblatt and J. Sipe, 
unpublished  observations).  However, it  may be that  C3H/HeN  macrophages alter 
K235  (ph)  LPS so that it is now stimulatory for C3H/HeJ mice. Such a  mechanism 
has been postulated  for induction  of B-cell  mitogenesis in  C3H/HeJ  mice by LPS 
(24).  The previously mentioned lability of SAA inducer in serum would seem to rule 
out this possibility. 
The  identification  of an  endotoxin-induced  mediator  of SAA  biosynthesis raises 
many interesting questions about its role in the synthesis of other acute phase reactants 
and inducible  liver proteins:  Does the SAA inducing  factor elicit other acute phase 
reactants such as CRP (12) and do the numerous inflammatory agents which stimulate 
an SAA response act via a common mediator or by different ones? Biochemical studies 
are currently in progress to isolate and characterize the endotoxin-produced mediator 
of SAA induction  from LPS-stimulated macrophage culture supernates. The in vitro 
induction  of SAA  by an  inflammatory agent,  such  as endotoxin,  has not  yet been 
described; clearly, the chemical characterization of SAA inducer will be facilitated by 
an in vitro assay. 
The existence of this newly recognized mediator of the inflammatory response also 
raises many interesting questions as to its role in amyloidogenesis. It may be that the 
same  mediator  acting  on  different  cell  populations  induces  AA  polypeptides  of 
different amino acid sequence; or that various mediators, which can induce different 
AA polypeptides, are produced according to the nature of the inflammatory agents. 
Perhaps an individual mediator of SAA induction may have a preferential affinity for 
the hepatocyte, but  when  present  in  high  concentrations  due  to prolonged  inflam- 
mation it may stimulate other tissues, such as spleen, to synthesize amyloid A protein 
(3, 25, 26). Thus, the chemistry and concentration of the mediator may be important 
in  the  pathogenesis  of  amyloidosis  as  well  as  factors  which  have  already  been 
recognized,  such  as microheterogeneity of the AA polypeptide  (25)  and proteolytic 
processing of the AA polypeptide (27). 
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production of SAA suggests a  plausible  mechanism by which chronic inflammation 
induces  amyloidosis.  The  isolation  and  characterization  of this  SAA  inducer  may 
greatly facilitate studies on the pathogenesis of amyloid0sis. 
Finally it will be interesting to learn whether the SAA inducer is newly synthesized 
in response to LPS or is released  by macrophages involved in the processing of LPS, 
and to learn if any other biological activities reside in the SAA inducer. SAA inducer 
appears to be distinct  from interferon because interferon was not detectable in latent 
period  serum,  and  because  mouse  interferon  did  not  induce  significant  amounts  of 
SAA (J.  Sipe, unpublished observations).  Future work will determine what relation- 
ship SAA inducer has to other mediators ofendotoxicity, such as tumor necrosis factor 
and GAF. 
Summary 
The mechanism by which LPS stimulates  an acute phase serum amyloid A  (SAA) 
response in C3H mice has been studied.  A  factor (SAA inducer)  appears in the blood 
of C3H/HeN  (iipopolysaccharide [LPS]-sensitive)  mice ~ 1 h  after administration  of 
LPS,  which,  when  passively  administered,  can  induce  C3H/HeJ  mice  to  produce 
SAA although they are resistant  to the LPS itself.  SAA inducer has been detected in 
the  culture  medium  of LPS  treated  C3H/HeN  macrophages  but  not  spleen  cells. 
Thus, two stages in the induction of the acutephase SAA response are now recognized: 
a  latent  period  of 2-3  h  during  which  the  SAA concentration  remains  at  baseline 
values and in which SAA inducer appears, and the period of synthesis of SAA which 
lasts  for -24  h  past  induction.  It is proposed that  a  macrophage response to LPS is 
responsible for production of the serum mediator which induces SAA synthesis. 
We are grateful to Dr. Robert M. Friedman for numerous helpful discussions,  to Dr. Suzanne 
Michalek for help with the bone marrow transfer experiments, and to Mr. Paul Bowie for his 
technical assistance. 
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